Remdesivir & COVID Studies Find Different Results

photo of virus coronavirus headline text

Disappointing results emerged from the first gold-standard clinical trial for remdesivir, which found that the drug did not help patients in China with severe COVID-19.

from WebMD Health https://ift.tt/2xkdBNj
via IFTTT

Comments

The Future of Autoimmune Disorders: Psoriatic Disease

What's being done to help people with psoriatic disease? We get a look at the ever-changing picture from a rheumatologist. from WebMD Health https://ift.tt/5P6ZHyd via IFTTT

Long COVID Experts: ‘So Incredibly Clear What’s at Stake’

It’s estimated that more than a third of people who have had COVID-19 experience neurological complications such as brain fog that persist or develop 3 months after infection. And two thirds of so-called long haulers still have neurological symptoms after 6 months. from WebMD Health https://ift.tt/mx1j6QD via IFTTT

Study: Black Men Twice as Likely to Develop Prostate Cancer as Whites

A review of men seen at VA hospitals found that Black veterans had nearly twice the incidence of localized and advanced prostate cancer as white men. from WebMD Health https://ift.tt/3Knscs2 via IFTTT

Beingcivilian

Search This Blog